Timing Considerations for Artificial Urinary Sphincter Implantation Postpelvic Radiotherapy

Area of Science:

• Urology
• Medical Devices
• Radiation Oncology

Background:

• Artificial urinary sphincters (AUS) are used to treat post-radiation therapy (RT) urinary incontinence.
• Optimal timing for AUS implantation after RT is not well-established.
• Previous urethral or bladder neck interventions may influence outcomes.

Purpose of the Study:

• To determine the optimal timing for artificial urinary sphincter (AUS) implantation following pelvic radiation therapy (RT).
• To evaluate the impact of implantation timing on device survival and revision/explantation rates.

Main Methods:

• Retrospective review of 72 patients receiving their first AUS after pelvic RT (2011-2023).
• Kaplan-Meier analysis compared device revision/explantation (Rev/Exp) rates for implantation earlier vs. later than 2, 3, 4, and 5 years post-RT.
• Pearson correlation assessed trends in Rev/Exp reasons (erosion/infection vs. other).

Main Results:

• 50% of devices (36/72) required revision or explantation, primarily due to mechanical failure (19.4%) and erosion (16.7%).
• No significant difference in device Rev/Exp risk was found when implanted within 2, 3, 4, or 5 years post-RT (P > 0.3 for all).
• A strong trend (R² = 0.98) indicated higher erosion/infection rates for later implantations.

Conclusions:

• Implanting an artificial urinary sphincter (AUS) within five years after radiation therapy (RT) is associated with comparable device survival.
• Later AUS implantation post-RT may be linked to increased rates of device removal due to erosion or infection.
• Further research with larger sample sizes is warranted to confirm these findings.